Advertisement
News
Advertisement

Reportlinker Adds U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments

Mon, 05/09/2011 - 3:32am
Bio-Medicine.Org

NEW YORK, May 9, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

U.S. Rheumatoid Arthritis Market: Assessment of Biologics and New Treatments

http://www.reportlinker.com/p0490687/US-Rheumatoid-Arthritis-Market-Assessment-of-Biologics-and-New-Treatments.html

This research service covers the U.S. rheumatoid arthritis (RA) market from 2007 to 2017, with 2010 as the base year. Included in this research service are products currently in the market, products in development, and patient forecasts. Market challenges, drivers, and restraints are identified and assessed. Strategic recommendations are presented to overcome listed industry challenges. This research service does not include market revenue forecasts for DMARDs. This research service highlights product forecasts for biologic products as well as small molecules near launch.

Table of Contents

Scope

10

Methodology

Methodology

11

Market Introduction

RA Background

13

Epidemiology

14

Risk Factors

15

Diagnosis

16

Treatment Paradigm

17

Patient Outlook

Patient Forecast of RA in the United States

19

RA Patients Requiring Add-on Therapy, Forecast in the United States

20

Patients Taking Add-on Therapy Forecast in the United States

21

Industry Challenges

23

Current Treatments

28

Key Trends

31

Market Drivers and Restraints

33

Market Drivers

34

Market Analysis and Forecast

'/>"/>

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading